Therapy Areas: Cardiovascular
Veradermics reports positive Phase 2/3 results for oral VDPHL01 in pattern hair loss treatment
27 April 2026 - Veradermics Inc (NYSE:MANE), a late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, on Monday announced positive topline results fr...
Thryv Therapeutics doses first patients in Wave II clinical study for Long QT Syndrome; THRV-1268 receives FDA Fast Track Designation
23 April 2026 - Thryv Therapeutics Inc, a Canada-based, clinical-stage biotechnology company advancing novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias...
Ondine Biomedical abstracts selected for 2026 World Congress on Infectious Diseases
22 April 2026 - Ondine Biomedical Inc (LON: OBI), a provider of photodisinfection-based therapies, announced on Wednesday that it has secured acceptance of two abstracts for poster presentation at the...
Philips secures FDA clearance for Spectral CT Verida system
...
Eli Lilly launches Foundayo weight‑loss pill in the US
...
Lilly's Foundayo (orforglipron) weight loss pill gains US FDA approval
2 April 2026 - Pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Wednesday that the US Food and Drug Administration (FDA) has approved Foundayo (orforglipron) for adults with obesit...